NCT00852423 arm group fb5b1ad3b4d1717d7ae199b8660e11d0 [clinicaltrials_resource:NCT00852423/arm-group/fb5b1ad3b4d1717d7ae199b8660e11d0]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00852423 arm group fb5b1ad3b4d1717d7ae199b8660e11d0 [clinicaltrials_resource:NCT00852423/arm-group/fb5b1ad3b4d1717d7ae199b8660e11d0]
Bio2RDF identifier
NCT00852423/arm-group/fb5b1ad3b4d1717d7ae199b8660e11d0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 5b1ad3b4d1717d7ae199b8660e11d0
description [clinicaltrials_vocabulary:description]
Three-day treatment with dihydroartemisinin-piperaquine
identifier
clinicaltrials_resource:NCT00852423/arm-group/fb5b1ad3b4d1717d7ae199b8660e11d0
title
NCT00852423 arm group fb5b1ad3b4d1717d7ae199b8660e11d0
@en
type
label
NCT00852423 arm group fb5b1ad3 ...... b1ad3b4d1717d7ae199b8660e11d0]
@en